How to Choose the Right Inhaler Using a Patient-Centric Approach?


Journal

Advances in therapy
ISSN: 1865-8652
Titre abrégé: Adv Ther
Pays: United States
ID NLM: 8611864

Informations de publication

Date de publication:
03 2022
Historique:
received: 17 11 2021
accepted: 20 12 2021
pubmed: 27 1 2022
medline: 16 3 2022
entrez: 26 1 2022
Statut: ppublish

Résumé

There are many different inhaler devices and medications on the market for the treatment of asthma and chronic obstructive pulmonary disease, with over 230 drug-delivery system combinations available. However, despite the abundance of effective treatment options, the achieved disease control in clinical practice often remains unsatisfactory. In this context, a key determining factor is the match or mismatch of an inhalation device with the characteristics or needs of an individual patient. Indeed, to date, no ideal device exists that fits all patients, and a personalized approach needs to be considered. Several useful choice-guiding algorithms have been developed in the recent years to improve inhaler-patient matching, but a comprehensive tool that translates the multifactorial complexity of inhalation therapy into a user-friendly algorithm is still lacking. To address this, a multidisciplinary expert panel has developed an evidence-based practical treatment tool that allows a straightforward way of choosing the right inhaler for each patient.

Identifiants

pubmed: 35080761
doi: 10.1007/s12325-021-02034-9
pii: 10.1007/s12325-021-02034-9
pmc: PMC8790222
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Pagination

1149-1163

Informations de copyright

© 2022. The Author(s).

Auteurs

Didier Cataldo (D)

Department of Respiratory Diseases, Tower of Pathology (B23), University of Liege (ULiege) and Centre Hospitalier Universitaire de Liège (CHU Liege), Hippocrates Avenue 13, 4000, Liège, Belgium. didier.cataldo@uliege.be.

Shane Hanon (S)

Respiratory Division, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090, Brussels, Belgium.

Rudi V Peché (RV)

Department of Respiratory Diseases, I.S.P.P.C, C.H.U. Charleroi, Hôpital André Vésale, 6110, Montigny-le-Tilleul, Belgium.

Daniel J Schuermans (DJ)

Respiratory Division, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), 1090, Brussels, Belgium.

Jean M Degryse (JM)

Department of Public Health and Primary Care, KU Leuven-University of Leuven, 3000, Leuven, Belgium.

Isabelle A De Wulf (IA)

Association of Pharmacists Belgium (APB), 1000, Brussels, Belgium.

Karin Elinck (K)

General Practitioner, 9000, Ghent, Belgium.

Mathias H Leys (MH)

Department of Respiratory Diseases, AZ Groeninge, 8500, Kortijk, Belgium.

Peter L Rummens (PL)

Department of Respiratory Medicine, University Hospital Saint-Pierre, Université Libre de Bruxelles, 1000, Brussels, Belgium.

Eric Derom (E)

Department of Respiratory Medicine, Ghent University Hospital, 9000, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH